• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国抗抑郁药处方模式:来自抑郁临床研究中心的研究结果。

Antidepressant prescribing patterns in Korea: results from the clinical research center for depression study.

机构信息

Department of Psychiatry, Chonnam National University Medical School, Gwangju, Korea.

出版信息

Psychiatry Investig. 2011 Sep;8(3):234-44. doi: 10.4306/pi.2011.8.3.234. Epub 2011 Aug 26.

DOI:10.4306/pi.2011.8.3.234
PMID:21994511
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3182389/
Abstract

OBJECTIVE

This study aimed to investigate antidepressant prescribing patterns, including initial choice, switching and combining, and concomitant use of non-antidepressant agents, for depressive disorders in naturalistic clinical care settings in Korea.

METHODS

Patients with depressive disorder were recruited from both outpatient and inpatient settings in 18 hospitals from all over Korea. Treatment was performed in naturalistic patterns based on each clinician's decision. Data were collected on the prescription of antidepressants and concomitant agents from baseline to 12-week follow-up.

RESULTS

Selective serotonin reuptake inhibitors (SSRIs) were the most commonly prescribed initial antidepressant (48.9%), followed by newer dual-action antidepressants (45.8%). When an SSRI was the initial antidepressant, 46.2% of patients whose medication was changed were moved to newer dual-action antidepressants, and 67.4% of combination cases were combined with newer dual-action ones. When a newer dual-action antidepressant was the initial antidepressant, 70.6% of patients whose medication was changed were moved to SSRIs, and other antidepressants including tricyclic antidepressants were most commonly added for combination treatment (50% of combination cases). During the treatment period, 20.6% of antidepressants prescribed were augmented by non-antidepressant agents, and 75.1% were used concomitantly with anxiolytics or hypnotics. The most commonly used concomitant non-antidepressant agent was quetiapine.

CONCLUSION

The selection of antidepressants and the concomitant use of non-antidepressant agents are becoming increasingly diversified, and the results of this study reflect changes in the prescribing pattern in actual Korean practices.

摘要

目的

本研究旨在调查韩国自然临床环境中治疗抑郁障碍的抗抑郁药处方模式,包括初始选择、转换和联合以及非抗抑郁药的伴随使用。

方法

在韩国的 18 家医院中,从门诊和住院患者中招募了患有抑郁障碍的患者。根据每位临床医生的决定,按照自然模式进行治疗。从基线到 12 周随访期间,收集了抗抑郁药和伴随药物的处方数据。

结果

选择性 5-羟色胺再摄取抑制剂(SSRIs)是最常被处方的初始抗抑郁药(48.9%),其次是新型双重作用抗抑郁药(45.8%)。当 SSRI 作为初始抗抑郁药时,46.2%的药物转换患者被转用新型双重作用抗抑郁药,67.4%的联合治疗患者与新型双重作用抗抑郁药联合使用。当新型双重作用抗抑郁药作为初始抗抑郁药时,70.6%的药物转换患者被转用 SSRI,其他抗抑郁药(包括三环抗抑郁药)最常用于联合治疗(50%的联合治疗患者)。在治疗期间,20.6%的处方抗抑郁药被非抗抑郁药增效,75.1%与抗焦虑药或催眠药同时使用。最常使用的伴随非抗抑郁药是喹硫平。

结论

抗抑郁药的选择和非抗抑郁药的伴随使用变得越来越多样化,本研究的结果反映了韩国实际实践中处方模式的变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cb1/3182389/8a856a38c389/pi-8-234-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cb1/3182389/0a4f90172799/pi-8-234-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cb1/3182389/784664bec3f3/pi-8-234-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cb1/3182389/8768613f92dc/pi-8-234-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cb1/3182389/8a856a38c389/pi-8-234-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cb1/3182389/0a4f90172799/pi-8-234-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cb1/3182389/784664bec3f3/pi-8-234-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cb1/3182389/8768613f92dc/pi-8-234-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cb1/3182389/8a856a38c389/pi-8-234-g004.jpg

相似文献

1
Antidepressant prescribing patterns in Korea: results from the clinical research center for depression study.韩国抗抑郁药处方模式:来自抑郁临床研究中心的研究结果。
Psychiatry Investig. 2011 Sep;8(3):234-44. doi: 10.4306/pi.2011.8.3.234. Epub 2011 Aug 26.
2
[Antidepressants consumption in the global population in France].[法国全球人口中的抗抑郁药消费情况]
Encephale. 2002 Sep-Oct;28(5 Pt 1):411-7.
3
Determinants of antidepressant medication prescribing in elderly residents of aged care homes in Australia: a retrospective study.澳大利亚老年护理院老年居民抗抑郁药物处方的决定因素:一项回顾性研究。
Am J Geriatr Pharmacother. 2009 Aug;7(4):210-9. doi: 10.1016/j.amjopharm.2009.07.001.
4
Concomitant prescribing of tranquilizers and hypnotics among patients receiving antidepressant prescriptions.接受抗抑郁药处方的患者中同时开具镇静剂和催眠药的情况。
Ann Pharmacother. 1998 May;32(5):531-5. doi: 10.1345/aph.17211.
5
A study of the safety and harms of antidepressant drugs for older people: a cohort study using a large primary care database.一项关于老年人抗抑郁药安全性和危害的研究:一项使用大型初级保健数据库的队列研究。
Health Technol Assess. 2011 Aug;15(28):1-202, iii-iv. doi: 10.3310/hta15280.
6
A Naturalistic Evaluation of Change in Antidepressant Prescription in Patients With Affective and Anxiety Disorders in a Tertiary Care Hospital of India.印度一家三级护理医院中情感障碍和焦虑症患者抗抑郁药处方变化的自然主义评估。
J Clin Psychopharmacol. 2018 Feb;38(1):47-50. doi: 10.1097/JCP.0000000000000822.
7
IPS multicentric study: Antidepressant prescription patterns.IPS 多中心研究:抗抑郁药处方模式。
Indian J Psychiatry. 2013 Jan;55(1):41-5. doi: 10.4103/0019-5545.105503.
8
Effects of the Committee on Safety of Medicines advice on antidepressant prescribing to children and adolescents in the UK.英国药品安全委员会的建议对英国儿童和青少年抗抑郁药处方的影响。
Drug Saf. 2005;28(12):1151-7. doi: 10.2165/00002018-200528120-00009.
9
Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.药物依从性和医疗资源利用模式的差异:老年与新型抗抑郁药在抑郁症和/或焦虑症患者中的应用
CNS Drugs. 2008;22(11):963-73. doi: 10.2165/00023210-200822110-00005.
10
Trends in Prescribing of Selective Serotonin Reuptake Inhibitors and Other Newer Antidepressant Agents in Adult Primary Care.成人初级保健中选择性5-羟色胺再摄取抑制剂及其他新型抗抑郁药的处方趋势
Prim Care Companion J Clin Psychiatry. 2003 Aug;5(4):153-157. doi: 10.4088/pcc.v05n0402.

引用本文的文献

1
Tricyclic antidepressants dose-dependently modulate the biphasic activity of the TRPC5 channel through opioid receptors.三环类抗抑郁药通过阿片受体对TRPC5通道的双相活性进行剂量依赖性调节。
Korean J Physiol Pharmacol. 2025 Jul 1;29(4):455-464. doi: 10.4196/kjpp.25.121.
2
Use of Antidepressants among Patients Diagnosed with Depression: A Scoping Review.诊断为抑郁症的患者中抗抑郁药的使用:范围综述。
Biomed Res Int. 2021 Mar 15;2021:6699028. doi: 10.1155/2021/6699028. eCollection 2021.
3
The epidemiology of antidepressant use in South Korea: Does short-term antidepressant use affect the relapse and recurrence of depressive episodes?

本文引用的文献

1
Relationship between a history of a suicide attempt and treatment outcomes in patients with depression.抑郁症患者自杀史与治疗结果的关系。
J Clin Psychopharmacol. 2011 Aug;31(4):449-56. doi: 10.1097/JCP.0b013e3182217d51.
2
Predictors of 12-week remission in a nationwide cohort of people with depressive disorders: the CRESCEND study.全国抑郁症患者队列中12周缓解的预测因素:CRESCEND研究
Hum Psychopharmacol. 2011 Jan;26(1):41-50. doi: 10.1002/hup.1168.
3
Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
韩国抗抑郁药使用的流行病学:短期抗抑郁药使用是否会影响抑郁发作的复发和再发?
PLoS One. 2019 Sep 25;14(9):e0222791. doi: 10.1371/journal.pone.0222791. eCollection 2019.
4
Which Patients Are Prescribed Escitalopram?: Predictors for Escitalopram Prescriptions and Functional Outcomes among Patients with Acute Ischemic Stroke.哪些患者被开了艾司西酞普兰?:急性缺血性脑卒中患者开艾司西酞普兰的预测因子及功能结局。
Int J Environ Res Public Health. 2018 May 28;15(6):1085. doi: 10.3390/ijerph15061085.
5
Clinical Validation of the Psychotic Depression Assessment Scale, Hamilton Depression Rating Scale-6, and Brief Psychiatric Rating Scale-5: Results from the Clinical Research Center for Depression Study.精神病性抑郁评定量表、汉密尔顿抑郁量表-6和简明精神病评定量表-5的临床验证:抑郁症临床研究中心的研究结果。
Psychiatry Investig. 2017 Sep;14(5):568-576. doi: 10.4306/pi.2017.14.5.568. Epub 2017 Sep 11.
6
Times to Discontinue Antidepressants Over 6 Months in Patients with Major Depressive Disorder.重度抑郁症患者停用抗抑郁药超过6个月的时间。
Psychiatry Investig. 2016 Jul;13(4):440-6. doi: 10.4306/pi.2016.13.4.440. Epub 2016 Jul 25.
米氮平与选择性 5-羟色胺再摄取抑制剂治疗缓解:15 项重度抑郁症急性期治疗对照试验的个体患者数据分析荟萃分析。
Int Clin Psychopharmacol. 2010 Jul;25(4):189-98. doi: 10.1097/YIC.0b013e328330adb2.
4
Quetiapine XR: current status for the treatment of major depressive disorder.喹硫平 XR:治疗重度抑郁症的现状。
Prog Neuropsychopharmacol Biol Psychiatry. 2010 Oct 1;34(7):1165-73. doi: 10.1016/j.pnpbp.2010.03.023. Epub 2010 Mar 20.
5
[Antidepressive efficacy of quetiapine XR in unipolar major depression--the role of early onset of action and sleep-improving effect in decreasing suicide risk].喹硫平缓释片治疗单相重度抑郁症的抗抑郁疗效——早期起效及改善睡眠对降低自杀风险的作用
Neuropsychopharmacol Hung. 2009 Dec;11(4):211-5.
6
Combining antidepressant therapies from the initiation of treatment: a paradigm shift for major depression.从治疗开始就联合使用抗抑郁疗法:重度抑郁症治疗模式的转变。
J Clin Psychiatry. 2009 Nov;70(11):1493-4. doi: 10.4088/JCP.09bs05697blu.
7
Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis.在成人抑郁症急性期治疗中,与其他抗抑郁药类别相比,随机对照试验中描述的米氮平的安全性报告和不良事件概况:系统评价和荟萃分析。
CNS Drugs. 2010 Jan;24(1):35-53. doi: 10.2165/11319480-000000000-00000.
8
Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.抗抑郁药联合治疗起始用于治疗重度抑郁症:一项双盲随机研究。
Am J Psychiatry. 2010 Mar;167(3):281-8. doi: 10.1176/appi.ajp.2009.09020186. Epub 2009 Dec 15.
9
Accelerating response to antidepressant treatment in depression: a review and clinical suggestions.加速抑郁症抗抑郁治疗反应:综述及临床建议。
Prog Neuropsychopharmacol Biol Psychiatry. 2010 Mar 17;34(2):259-64. doi: 10.1016/j.pnpbp.2009.12.001. Epub 2009 Dec 5.
10
Utility of atypical antipsychotics in the treatment of resistant unipolar depression.非典型抗精神病药物在难治性单相抑郁治疗中的效用。
CNS Drugs. 2009;23(5):369-77. doi: 10.2165/00023210-200923050-00002.